The hypoglycemia safety net: updated recommendations to optimize patient outcomes

Managing hypoglycemia remains a persistent, high-stakes challenge for both clinicians and the patients they support. What are the updates to the Diabetes Canada Clinical Practice Guidelines for Hypoglycemia and how can these be integrated into daily practice immediately?

Our host, Dr. Jeremy Gilbert, an Endocrinologist at Sunnybrook Health Sciences Centre and Associate Professor at the University of Toronto, discusses standardizing hypoglycemia safety with Dr. Akshay Jain, a Clinical Endocrinologist and Medical Director for Research at Unity Healthcare based in Surrey, British Columbia.

Together, our experts explore the complex clinical realities and systemic gaps surrounding hypoglycemia management. They discuss the practical implications of the updated Diabetes Canada guidelines, detailing the new three-level classification of hypoglycemia, and the symptoms associated with each level. They highlight the importance of prevention, strategies for monitoring, and important conversations to have with patients about hypoglycemia. Tune in to hear practical, actionable tips for managing hypoglycemia to better support individuals living with diabetes.

Don’t miss the conversation! 

The views and opinions expressed in this episode are those of the speakers, and do not necessarily reflect the views or positions of any entities they represent. 

Declaration of conflict of interest:  

Dr. Jeremy Gilbert:

• Direct financial relationship, including receipt of honoraria: CPD Network, LMC Canada Inc., CSEM, S+L Solutions, Liv Agency, Unik Agency, STA. Membership on advisory boards or speaker’s bureaus: Abbott, Amgen, Bayer, Insulet, Tandem, Boehringer Ingelheim, Eli Lilly, GSK, HLS Therapeutics, Novartis, Novo Nordisk.

Dr. Akshay Jain:

• Direct financial relationship, including receipt of honoraria: Abbott, Abbvie, AstraZeneca, Amgen, Antibody, Bausch Healthcare, Bayer, Boehringer Ingelheim, Care to Know, CCRN, Connected in Motion, CPD Network, Dexcom, Diabetes Canada, Eli Lilly, Embecta, EOCI, GSK, HLS Therapeutics, Janssen, Liv, Master Clinician Alliance, MDBriefcase, Merck, Medtronic, Moderna, NP Circle, Novartis, Novo Nordisk, Partners in Progressive Medical Education, Pfizer, Roche, Six Degrees, Timed Right, Unik, WebMD. Membership on advisory boards or speaker’s bureaus: Abbott, AstraZeneca, Amgen, Bausch Healthcare, Bayer, Boehringer Ingelheim, Dexcom, Eli Lilly, Embecta, Gilead Sciences, GSK, HLS Therapeutics, Industrii, Insulet, Janssen, Medtronic, NP Circle, Novartis, Novo Nordisk, Partners in Progressive Medical Education, Pendopharm, PocketPills, Roche, Sandoz, Takeda, Ypsomed. Funded grants, research, or clinical trials: Abbott, Amgen, Argenx, Astra Zeneca, Novo Nordisk, Roche, Sanofi.

MAT-CA-2600837